细胞治疗工艺：全球市场与技术

全球细胞治疗加工市场预计将从 2025 年的 27 亿美元成长到 2030 年的 71 亿美元，2025 年至 2030 年的复合年增长率为 21.4%。

预计北美市场将从2025年的12亿美元成长到2030年的33亿美元，2025年至2030年的复合年增长率为22.2%。预计亚太市场将从2025年的5.687亿美元成长到2030年的18亿美元，2025年至2030年的复合年增长率为25.5%。

本报告考察了全球细胞治疗加工市场，并提供了市场概况、市场影响因素和市场机会分析、市场规模趋势和预测，以及按各个细分市场和地区进行的详细分析。

目录

第一章执行摘要

• 市场展望
• 调查范围
• 市场摘要
• 概述
• 当前市场情势
• 细分市场分析
• 区域市场洞察
• 新兴技术
• 结论

第二章 市场概览

• 概述
• 细胞疗法生产工艺
• 细胞治疗供应链
• 宏观经济因素分析
• 人口统计因素
• 地缘政治因素
• 美国关税的影响
• 波特五力分析

第三章 市场动态

• 市场动态
• 市场驱动因素
• 对再生医学的需求日益增长
• 加大细胞和基因治疗（CGT）研究的投资
• 拓展临床和商业活动
• 加强策略性倡议
• 人口老化和慢性病增加
• 市场限制
• 复杂製造与供应链
• 高昂的开发成本
• 熟练劳动力短缺
• 监管障碍
• 市场机会
• 分散式製造
• 过渡到同种异体疗法

第四章：监理现状

• 概述
• 各国的监管情景
• 美国食品药物管理局
• 欧洲
• 亚太地区

第五章 新兴科技与发展

• 重点总结
• 自动化
• 第一代自动化平台
• 第二代自动化平台
• 一次性技术和小型化

第六章 市场区隔分析

• 概述
• 细分市场分析
• 按产品类型分類的市场分析
• 重点总结
• 产品
• 服务
• 软体
• 市场分析：按应用领域
• 重点总结
• 癌症
• 肌肉骨骼疾病（骨骼和骨骼肌修復）
• 神经系统疾病
• 心血管疾病
• 其他的
• 地理细分
• 按地区分類的市场分析
• 重点总结
• 北美洲
• 欧洲
• 亚太地区
• 其他地区

第七章 竞争讯息

• 重点总结
• 竞争分析
• 策略倡议
• 协议、合作与伙伴关係
• 获得
• 投资与扩张

第八章 细胞治疗加工市场的永续性：ESG视角

• ESG简介
• 细胞治疗加工产业的永续性
• 环境因素
• 社会因素
• 管治因素
• ESG永续发展趋势与倡议
• 环境绩效
• 社会表现
• 管治绩效
• ESG风险评估
• 结论

第九章附录

• 调查方法
• 资讯来源
• 简称
• 公司简介
• BIO-TECHNE
• BIOSPHERIX LLC.
• CYTIVA
• FRESENIUS KABI AG
• FUJIFILM BIOSCIENCES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• REVVITY
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• TERUMO CORP.
• THERMO FISHER SCIENTIFIC INC.
• THERMOGENESIS
• Start-Ups创业公司/市场颠覆者

The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030.

The North American market for cell therapy processing is estimated to grow from $1.2 billion in 2025 to reach $3.3 billion by 2030, at a CAGR 22.2% from 2025 to 2030.

The Asia-Pacific market for cell therapy processing is estimated to grow from $568.7 million in 2025 to reach $1.8 billion by 2030, at a CAGR 25.5% from 2025 to 2030.

Report Scope

The report provides an overview of global cell therapy processing and analyzes market trends. It includes global revenue ($ millions) for the base year data 2024 and estimated data for 2025 with forecasts through 2030. The market is segmented based on offering type, application and regions. By offering, the market is segmented into products, software and services. By application, the market is segmented into cancer, musculoskeletal disorders, neurological disorders, cardiovascular diseases and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East, Africa, and South America, focusing on the major countries in these regions. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the significant driving trends and challenges that affect the market. It analyzes environmental, social and corporate governance (ESG) developments. It includes an analysis of the competitive landscape and has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.

Report Includes

• 32 data tables and 58 additional tables
• An overview of the global market and technologies for cell therapy processing
• In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to the cell therapy processing, accompanied by a market share analysis by offerings, application and region
• Analysis of current and future demand in the global cell therapy processing market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• Analysis of drivers, challenges and opportunities affecting market growth
• Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
• Market share analysis of the key market participants in the cell therapy processing market, along with their research priorities, product portfolios, global rankings and company competitive landscape
• Profiles of the major companies, including Thermo Fisher Scientific Inc., Danaher Corp., Lonza, Miltenyi Biotech and Sartorius AG

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Market Insights
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Cell Therapy Manufacturing Process
• Cell Therapy Supply Chain
• Macroeconomic Factors Analysis
• Demographic Factors
• Geopolitical Factors
• Impact of U.S. Tariffs
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Growing Demand for Regenerative Medicine
• Increasing Investments in Cell and Gene Therapy (CGT) Research
• Expanding Clinical and Commercial Activities
• Growing Number of Strategic Initiatives
• Rising Aging Population and the Increasing Prevalence of Chronic Diseases
• Market Restraints
• Complex Manufacturing and Supply Chain
• High Cost of Development
• Lack of Skilled Workforce
• Regulatory Hurdles
• Market Opportunities
• Decentralized Manufacturing
• Shift Toward Allogeneic Therapies

Chapter 4 Regulatory Landscape

• Overview
• Regulatory Scenario by Country/Region
• U.S. FDA
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• Automation
• First-Generation Automated Platforms
• Second-Generation Automated Platforms
• Single-Use Technologies and Miniaturization

Chapter 6 Market Segment Analysis

• Overview
• Segmentation Breakdown
• Market Analysis by Type of Offerings
• Key Takeaways
• Products
• Services
• Software
• Market Analysis by Application
• Key Takeaways
• Cancer
• Musculoskeletal Disorders (Bone and Skeletal Muscle Repair)
• Neurological Disorders
• Cardiovascular Disorders
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Agreements, Collaborations and Partnerships
• Acquisitions
• Investments and Expansions

Chapter 8 Sustainability in Cell Therapy Processing Market: An ESG Perspective

• Introduction to ESG
• Sustainability in the Cell Therapy Processing Industry
• Environmental Factors
• Social Factors
• Governance Factors
• ESG Sustainability Trends and Initiatives
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks

Chapter 9 Appendix

• Research Methodology
• Information Sources
• Abbreviations
• Company Profiles
• BIO-TECHNE
• BIOSPHERIX LLC.
• CYTIVA
• FRESENIUS KABI AG
• FUJIFILM BIOSCIENCES
• LONZA
• MERCK KGAA
• MILTENYI BIOTEC
• PROTEINTECH GROUP INC.
• REVVITY
• SARTORIUS AG
• STEMCELL TECHNOLOGIES
• TERUMO CORP.
• THERMO FISHER SCIENTIFIC INC.
• THERMOGENESIS
• Emerging Start-ups/Market Disruptors

List of Tables

• Summary Table : Global Market for Cell Therapy Processing, by Region, Through 2030
• Table 1 : Classification of Stem Cells
• Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
• Table 3 : Comparison Between Autologous and Allogeneic Therapeutics
• Table 4 : Regulations for Advanced Therapies in the Asia-Pacific Region
• Table 5 : Global Market for Cell Therapy Processing, by Offering, Through 2030
• Table 6 : Global Market for Cell Therapy Processing Products, by Region, Through 2030
• Table 7 : Global Market for Cell Therapy Processing Services, by Region, Through 2030
• Table 8 : Global Market for Cell Therapy Processing Software, by Region, Through 2030
• Table 9 : Global Market for Cell Therapy Processing, by Application, Through 2030
• Table 10 : Global Market for Cell Therapy Processing for Oncology, by Region, Through 2030
• Table 11 : Global Market for Cell Therapy Processing for Musculoskeletal Disorders, by Region, Through 2030
• Table 12 : Global Market for Cell Therapy Processing for Neurological Disorders, by Region, Through 2030
• Table 13 : Global Market for Cell Therapy Processing for Cardiovascular Disorders, by Region, Through 2030
• Table 14 : Global Market for Cell Therapy Processing for Other Disease Indications, by Region, Through 2030
• Table 15 : Global Market for Cell Therapy Processing, by Region, Through 2030
• Table 16 : North American Market for Cell Therapy Processing, by Offering, Through 2030
• Table 17 : North American Market for Cell Therapy Processing, by Application, Through 2030
• Table 18 : North American Market for Cell Therapy Processing, by Country, Through 2030
• Table 19 : European Market for Cell Therapy Processing, by Offering, Through 2030
• Table 20 : European Market for Cell Therapy Processing, by Application, Through 2030
• Table 21 : European Market for Cell Therapy Processing, by Country, Through 2030
• Table 22 : Asia-Pacific Market for Cell Therapy Processing, by Offering, Through 2030
• Table 23 : Asia-Pacific Market for Cell Therapy Processing, by Application, Through 2030
• Table 24 : Asia-Pacific Market for Cell Therapy Processing, by Country, Through 2030
• Table 25 : RoW Market for Cell Therapy Processing, by Offering, Through 2030
• Table 26 : RoW Market for Cell Therapy Processing, by Application, Through 2030
• Table 27 : RoW Market for Cell Therapy Processing, by Sub-Region, Through 2030
• Table 28 : Global Ranking of Players: Cell Therapy Processing Market, 2024
• Table 29 : Agreements, Collaborations and Partnerships: Cell Therapy Processing Market, 2021-2025
• Table 30 : Acquisitions: Cell Therapy Processing Market, 2022-2025
• Table 31 : VC Investments and Expansion Activities: Cell Therapy Processing Market, 2022-2025
• Table 32 : ESG: Environmental Overview
• Table 33 : ESG: Social Overview
• Table 34 : ESG: Governance Overview
• Table 35 : ESG Risk Rankings for Cell Therapy Processing Market Companies, 2025
• Table 36 : Information Sources in this Report
• Table 37 : Abbreviations Used in the Cell Therapy Processing Market Report
• Table 38 : Bio-Techne: Company Snapshot
• Table 39 : Bio-Techne: Financial Performance, FY 2023 and 2024
• Table 40 : Bio-Techne: Product Portfolio
• Table 41 : Bio-Techne: News/Key Developments, 2022-2025
• Table 42 : BioSpherix LLC.: Company Snapshot
• Table 43 : BioSpherix LLC.: Product Portfolio
• Table 44 : BioSpherix LLC.: News/Key Developments, 2022-2025
• Table 45 : Cytiva.: Company Snapshot
• Table 46 : Cytiva: Product Portfolio
• Table 47 : Cytiva: News/Key Developments, 2021-2024
• Table 48 : Fresenius Kabi AG: Company Snapshot
• Table 49 : Fresenius Kabi AG: Financial Performance, FY 2023 and 2024
• Table 50 : Fresenius Kabi AG: Product Portfolio
• Table 51 : Fresenius Kabi AG: News/Key Developments, 2022-2024
• Table 52 : Fujifilm Biosciences: Company Snapshot
• Table 53 : Fujifilm Biosciences: Product Portfolio
• Table 54 : Fujifilm Biosciences: News/Key Developments, 2022-2025
• Table 55 : Lonza: Company Snapshot
• Table 56 : Lonza: Financial Performance, FY 2023 and 2024
• Table 57 : Lonza: Product Portfolio
• Table 58 : Lonza: News/Key Developments, 2021-2024
• Table 59 : Merck KGaA: Company Snapshot
• Table 60 : Merck KGaA.: Financial Performance, FY 2023 and 2024
• Table 61 : Merck KGaA: Product Portfolio
• Table 62 : Merck KGaA.: News/Key Developments, 2021-2025
• Table 63 : Miltenyi Biotec: Company Snapshot
• Table 64 : Miltenyi Biotec: Product Portfolio
• Table 65 : Miltenyi Biotec: News/Key Developments, 2023-2024
• Table 66 : Proteintech Group Inc.: Company Snapshot
• Table 67 : Proteintech Group Inc.: Product Portfolio
• Table 68 : Revvity: Company Snapshot
• Table 69 : Revvity: Financial Performance, FY 2023 and 2024
• Table 70 : Revvity: Product Portfolio
• Table 71 : Revvity: News/Key Developments, 2024 and 2025
• Table 72 : Sartorius AG: Company Snapshot
• Table 73 : Sartorius AG: Financial Performance, FY 2023 and 2024
• Table 74 : Sartorius AG: Product Portfolio
• Table 75 : Sartorius AG: News/Key Developments, 2023-2024
• Table 76 : STEMCELL Technologies: Company Snapshot
• Table 77 : STEMCELL Technologies: Product Portfolio
• Table 78 : STEMCELL Technologies: News/Key Developments, 2022-2025
• Table 79 : Terumo Corp.: Company Snapshot
• Table 80 : Terumo Corp.: Financial Performance, FY 2023 and 2024
• Table 81 : Terumo Corp.: Product Portfolio
• Table 82 : Terumo Corp.: News/Key Developments, 2021-2025
• Table 83 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 84 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
• Table 85 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 86 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
• Table 87 : ThermoGenesis: Company Snapshot
• Table 88 : ThermoGenesis: Product Portfolio
• Table 89 : List of a Few Emerging Startups in the Cell Therapy Processing Market

List of Figures

• Summary Figure : Global Market Shares of Cell Therapy Processing, by Region, 2024
• Figure 1 : Porter's Five Forces Analysis of the Cell Therapy Processing Market
• Figure 2 : Snapshot of the Market Dynamics for Cell Therapy Processing
• Figure 3 : CGT Market Investments, by Year, 2019-2024
• Figure 4 : CGT Market Investments, by Deal Type, H1 2025
• Figure 5 : Global Market Shares of Cell Therapy Processing, by Offering Type, 2024
• Figure 6 : Global Market Shares of Cell Therapy Processing, by Application, 2024
• Figure 7 : Global Market Shares of Cell Therapy Processing, by Region, 2024
• Figure 8 : North American Market Shares of Cell Therapy Processing, by Country, 2024
• Figure 9 : European Market Shares of Cell Therapy Processing, by Country, 2024
• Figure 10 : Asia-Pacific Market Shares of Cell Therapy Processing, by Country, 2024
• Figure 11 : RoW Market Shares of Cell Therapy Processing, by Sub-Region, 2024
• Figure 12 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
• Figure 13 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
• Figure 14 : Fresenius Kabi AG: Revenue Share, by Business Unit, FY 2024
• Figure 15 : Lonza: Revenue Share, by Business Unit, FY 2024
• Figure 16 : Lonza: Revenue Share, by Country/Region, FY 2024
• Figure 17 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
• Figure 18 : Merck KGaA.: Revenue Share by Country/Region, FY 2024
• Figure 19 : Revvity: Revenue Share, by Business Unit, FY 2024
• Figure 20 : Revvity: Revenue Share, by Country/Region, FY 2024
• Figure 21 : Sartorius AG: Revenue Share, by Business Unit, FY 2024
• Figure 22 : Sartorius AG: Revenue Share, by Country/Region, FY 2024
• Figure 23 : Terumo Corp.: Revenue Share, by Business Unit, FY 2024
• Figure 24 : Terumo Corp.: Revenue Share, by Country/Region, FY 2024
• Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
• Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024